Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

Blocking BET Family Proteins Prevents Activation of Inflammatory Genes

By BiotechDaily International staff writers
Posted on 12 Mar 2013
A recent paper showed how members of the BET (Bromodomain Extra Terminal) family of dual bromodomain-containing transcriptional regulator proteins directly control the activation of inflammatory genes that contribute to a wide range of diseases from type II diabetes to cancer.

A bromodomain is a protein domain that recognizes acetylated lysine residues such as those on the N-terminal tails of histones. This recognition is often a prerequisite for protein-histone association and chromatin remodeling. The domain itself adopts an all-alpha protein fold, a bundle of four alpha helices.

Investigators at the Boston University School of Medicine (MA, USA) explored the hypothesis that members of the BET family directly controlled inflammatory genes. They examined the genetic model of brd2 lo mice, a strain with deficient BET proteins, to show that Brd2 was essential for proinflammatory cytokine production in macrophages.

The investigators used two methods to examine the role of Brd2. One was genetic knockdown of Brd2 gene activity with small interfering RNA (siRNA), and the other was by chemical inhibition of BET protein binding with the small molecule JQ1. This protein associates with transcription complexes and with acetylated chromatin during mitosis, and it selectively binds to the acetylated lysine-12 residue of histone H4 via its two bromodomains.

Results published in the February 18, 2013, online edition of the Journal of Immunology revealed that Brd2 and the closely related Brd4 physically associated with the promoters of inflammatory cytokine genes in macrophages. This association was absent in the presence of BET inhibition by JQ1. Furthermore, JQ1 abolished cytokine production in vitro and blunted the “cytokine storm” in endotoxemic mice by reducing levels of interleukin-6 and tumor necrosis factor-alpha while rescuing mice from LPS (lipopolysaccharide)-induced death. Therefore, targeting BET proteins with small-molecule inhibitors may benefit hyperinflammatory conditions associated with high levels of cytokine production.

“Our study suggests that it is not a coincidence that patients with diabetes experience higher risk of death from cancer, or that patients with chronic inflammatory diseases, such as atherosclerosis and insulin resistance, also are more likely to be obese or suffer from inflammatory complications,” said first author Dr. Anna C. Belkina, a researcher in molecular medicine at the Boston University School of Medicine. “This requires us to think of diverse diseases of different organs as much more closely related than our current division of medical specialties allows.”

Related Links:
Boston University School of Medicine



comments powered by Disqus

Channels

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Lab Technologies

view channel

White-Matter Deficits Found in Codeine-Containing Cough Syrup Users

A magnetic resonance imaging (MRI) study of chronic users of codeine-containing cough syrups (CCS) has found deficits in specific regions of brain white matter and linked these changes with increased impulsivity in codeine-containing cough syrup users. These findings were consistent with findings from earlier research of... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.